Business
Schedule One Update
Schedule One Update.
About this update from Hvivo Plc
[{"type":"text","content":"\n \nRNS Number : 0696A Open Orphan PLC 16 January 2020 \n\nPre-Admission Announcement\nEuronext Growth Schedule 1\n\n\n\n\nAnnouncement to be made by the Applicant prior to admission in accordance with the Euronext Growth Markets Rule Book\n\n\n\n\n\nAll Applicants must complete the following\n\n\n\n\n\nCompany name \nOpen Orphan plc (\"Open Orphan\" or the \"Company\", and together with its subsidiaries the \"Group\")\n \n\n\n \n\n\n\n\nCompany registered address and if different, company trading address (including postcodes)\n\n\n\n\n \nRegistered Office:\n \nPO Box W1J 6BD, Berkley Square House, 2nd Floor, Mayfair, London, W1J 8DJ\n \nTrading Offices:\n \n19 Railway Road, Dalkey, Dublin, Ireland\nQueen Mary BioEnterprises (QMB) Innovation Centre, 42 New Road, London, E1 2AX\n \n \n\n\n\n\nCountry of incorporation \n \nEngland and Wales\n \n\n\n \n\n\n\n\nCompany website address containing all information required by rule 26 (5.26) of the Euronext Growth Markets Rule Books\n\n\n\n\nwww.openorphan.com\n \n\n\n\n\nCompany business (including main country of operation) or, in the case of an investing company, details of its investing strategy. If the admission is sought as a result of a reverse takeover under rule 5.19 of the Euronext Growth Markets Rule Books, this should be stated\n \nThis is a reverse takeover under Rule 14.\n \nOpen Orphan is a Clinical Research Organisation that specialises in rare and orphan drugs. The headquarters are in Dublin, Ireland and the company also has offices in the UK, France, the Netherlands and Germany.\n \n\n\n\n\n \n\n\n\n\nDetails of securities to be admitted including any restrictions as to transfer of securities (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):\n \nNumber of ordinary shares of 0.1 pence each in nominal value (\"Ordinary Shares\") for which Admission will be sought: 445,622,374\n \nThere are no restrictions as to the transferability of the Ordinary Shares and no Ordinary Shares will be held in treasury.\n \n\n\n\n\n \n\n\n\n \n \n \n\n\n\n \n\n\n\n\nCapital to be raised on admission (if applicable) and anticipated market capitalis...